Clinical effect of esophageal variceal ligation in treatment of esophageal variceal bleeding in patients with liver cirrhosis
-
摘要:
目的观察内镜下食管静脉曲张套扎术(EVL)治疗肝硬化食管静脉曲张破裂出血(EVB)的临床疗效。方法收集2010年12月-2013年7月广东医科大学附属深圳市第三人民医院收治的肝硬化EVB患者84例,随机分为套扎组(A组,应用EVL联合生长抑素、埃索美拉唑治疗)、对照组(B组,应用生长抑素、埃索美拉唑治疗),每组42例。观察2组止血率、再出血率、并发症发生率、病死率等,了解EVL后静脉曲张根除率、早期再出血相关危险因素。符合正态分布的计量资料2组间比较采用t检验,多组间比较采用方差分析;不符合正态分布的计量资料2组间比较采用Mann-Whitney U检验,组内两两比较采用Wilcoxn符号秩和检验,多组间比较采用Kruskal-Wallis H检验。计数资料组间比较采用χ2检验或Fisher确切概率法。生存率的计算采用KaplanMeier法,比较不同组别的生存情况采用log-rank检验。二分类资料的影响因素分析采用logistic回归方法。结果 A、B 2组止血率分别为97.62%、80.95%,差异有统计学意义(P=0.029)。A组1年2
Abstract:Objective To investigate the clinical effect of endoscopic esophageal variceal ligation( EVL) in the treatment of esophageal variceal bleeding( EVB) in patients with liver cirrhosis. Methods A total of 84 liver cirrhosis patients with EVB who were admitted to The Third People's Hospital of Shenzhen,Guangdong Medical University,from December 2010 to July 2013 were divided into ligation group( group A,treated with EVL combined with somatostatin and esomeprazole) and control group( group B,treated with somatostatin and esomeprazole),with 42 patients in each group. The hemostasis rate,rebleeding rate,incidence rate of complications,and mortality rate were observed in both groups,as well as the variceal eradication rate after EVL and risk factors for early rebleeding. The t- test was used for comparison of normally distributed continuous data between two groups,and an analysis of variance was used for comparison between multiple groups; the Mann- Whitney U test was used for comparison of non- normally distributed continuous data between two groups,the Wilcoxon signed- rank sum test was used for comparison within each group,and the Kruskal- Wallis H test was used for comparison between multiple groups. The chi- square test or Fisher's exact test was used for comparison of categorical data between groups. The Kaplan- Meier method was used to calculate survival rates,and the log- rank test was used to compare survival rates between groups. The logistic regression method was used to investigate the influencing factors for dichotomous data. Results There was a significant difference in the hemostasis rate between groups A and B( 97. 62% vs 80. 95%,P = 0. 029). Compared with group B,group A had significantly lower rebleeding rates in 1-2 years( 15. 38% vs 38. 89%,χ~2= 5. 323,P = 0. 021) and 2- 3 years( 15. 38% vs 48. 48%,χ~2= 10. 448,P = 0. 001). A total of 14patients( 33. 33%) in group A and 7 patients( 16. 67%) in group B experienced adverse events,and 4 patients in group A and 9 patients in group B died within 3 years. Group A had significant improvements in the levels of alanine aminotransferase( ALT) and aspartate aminotransferase at 1 week after treatment( Z =- 2. 177 and- 2. 044,P = 0. 029 and 0. 041). Both groups had significant improvements in prothrombin time activity( PTA),prothrombin time( PT),international normalized ratio( INR),and albumin at 1 week after treatment( group A: Z =- 4. 007,t = 3. 866,Z =- 4. 152,t =- 4. 623,all P < 0. 001; group B: t =- 5. 069,Z =- 3. 870,Z =- 3. 909,Z =-5. 245,all P < 0. 001). There was a significant difference in PTA at 1 week after treatment between the two groups( Z =- 3. 902,P <0. 001). In group A,the overall disappearance rate of varices was 85. 71% and the recurrence rate was 14. 29%,and there was a significant correlation between the Child- Pugh score and diameter of the portal vein( F = 3. 319,P = 0. 047). Symptoms on admission,length of hospital stay,Child- Pugh score,spontaneous bacterial peritonitis,diameter of the portal vein,PT,INR,and ALT were risk factors for early rebleeding after ligation( all P < 0. 05). Conclusion EVL is a safe and effective method for the treatment of EVB in patients with liver cirrhosis and causes few complications.
-
Key words:
- liver cirrhosis /
- ligation /
- esophageal and gastric varices /
- treatment outcome
-
[1]BOSCH J,ABRALDES JG,BERZIGOTTI A,et al.Portal hypertension and gastrointestinal bleeding[J].Semin Liver Dis,2008,28(1):3-25. [2]MAO P,XIANG YL.Cause of early and late rebleeding after endoscopic variceal ligation and the nursing[J].China J Endosc,2013,19(7):732-735.(in Chinese)毛平,向亚利.内镜下套扎治疗食管静脉曲张术后早、晚期再出血的原因分析及处理[J].中国内镜杂志,2013,19(7):732-735. [3] The esophageal and gastric varices group of the digestive endoscopy branch of the Chinese Medical Association.Specification for endoscopic diagnosis and treatment of gastrointestinal varices and bleeding(2009)[J].Chin J Dig Endosc,2010,27(1):1-4.(in Chinese)中华医学会消化内镜学分会食管胃静脉曲张学组.消化道静脉曲张及出血的内镜诊断和治疗规范试行方案(2009年)[J].中华消化内镜杂志,2010,27(1):1-4. [4]Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association;Chinese Society of Endoscopy,Chinese Medical Association.Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J].J Clin Hepatol,2016,32(2):203-219.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志,2016,32(2):203-219. [5]WANG GL,WEN P,WEN JB,et al.Cost-effective analysis of pituitrin and somatostatin in treating esophageal and gastricvariceal bleeding[J].Mod J Integr Tradit Chin West Med,2010,19(18):2217-2218.(in Chinese)王桂良,文萍,文剑波,等.垂体后叶素与生长抑素治疗食管-胃底静脉曲张破裂出血成本-效果分析[J].现代中西医结合杂志,2010,19(18):2217-2218. [6]HUANG GM,MA MY,ZHUANG ZH,et al.Effect of sengstaken-blakemore tube combined with suction catheter in esophageal varices bleeding patients[J].Chin Crit Care Med,2013,25(9):554-555.(in Chinese)黄国敏,马明远,庄志浩,等.三腔二囊管联合自制食道囊上注吸管在治疗食管胃底静脉曲张破裂出血中的应用[J].中华危重病急救医学,2013,25(9):554-555. [7]YAO J,ZUO L,AN G,et al.Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma and portal hypertension[J].J Gastrointestin Liver Dis,2015,24(3):301-307. [8]ASCHA M,ABUQAYYAS S,HANOUNEH I,et al.Predictors of mortality after transjugular portosystemic shunt[J].World J Hepatol,2016,8(11):520-529. [9]JU W,ZHANG BJ,HAN GH.Long-term therapeutic effect of transjugular intrahepatic portosystemic shunt in patierts with intractable cirrhotic ascites and prognostic factors[J].J Clin Hepatol,2016,32(8):1529-1533.(in Chinese)巨伟,张博静,韩国宏.经颈静脉肝内门体分流术治疗肝硬化顽固性腹水的长期效果及预后因素分析[J].临床肝胆病杂志,2016,32(8):1529-1533. [10]DUAN XH,HAN XW,REN JZ,et al.Percutaneous transhepatic variceal embolization followed with partial splenic embolization for the acute variceal massive hemorrhage in cirrhosis[J].Chin J Hepatol,2015,23(5):372-375.(in Chinese)段旭华,韩新巍,任建庄,等.经皮胃冠状静脉栓塞术序贯脾栓塞治疗肝硬化消化道大出血的疗效观察[J].中华肝脏病杂志,2015,23(5):372-375. [11]BARI K,GARCIA-TSAO G.Treatment of portal hypertension[J].World J Gastroenterol,2012,18(11):1166-1175. [12]DAI C,LIU WX,JIANG M,et al.Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage:a meta-analysis[J].World J Gastroenterol,2015,21(8):2534-2541. [13]FENG RB.Endoscopic variceal ligation withβ-blockers for prevention of secondary variceal bleeding in cirrhosis:a Meta-analysis[J].China Med Herald,2015,12(2):74-78.(in Chinese)冯瑞兵.内镜下套扎术联合β-受体阻滞剂预防肝硬化食管静脉曲张再出血的Meta分析[J].中国医药导报,2015,12(2):74-78. [14]YU ZL.A re-evaluation of the efficacy of endoscopic ligation in the treatment of esophageal varices[J].Chin J Dig Endosc,2003,20(2):5-7.(in Chinese)于中麟.内镜下套扎治疗食管静脉曲张疗效的再评价[J].中华消化内镜杂志,2003,20(2):5-7. 期刊类型引用(21)
1. 王权,李先裴,魏晓广. 内镜下食管胃底静脉曲张栓塞套扎术联合生长抑素治疗肝硬化食管胃底静脉曲张出血的效果. 临床医学. 2024(01): 66-69 . 百度学术
2. 吴洪文,孙坤,谢宜奎. 内镜下套扎联合聚桂醇和蛇毒血凝酶血管内精准注射治疗食管静脉曲张破裂出血的效果. 蛇志. 2023(02): 162-164+184 . 百度学术
3. 王翠云. EVL联合EIS治疗肝硬化上消化道出血的近期与远期效果. 中外医学研究. 2023(20): 18-21 . 百度学术
4. 王明荣. 生长抑素联合内镜下食管静脉曲张套扎术治疗肝硬化食管静脉曲张破裂出血的临床效果. 临床医学研究与实践. 2023(33): 91-94 . 百度学术
5. 朱海洋,高红伟,孙会卿. 食管静脉套扎联合生长抑素治疗肝硬化并发食管静脉曲张破裂出血的临床效果分析. 医药论坛杂志. 2022(08): 59-62 . 百度学术
6. 周晓鲁. 内镜下密集套扎法治疗肝硬化并食管静脉曲张患者的疗效评价. 黑龙江医药科学. 2022(03): 172-173 . 百度学术
7. 石小静,申军华,牛红梅,李云,苏淼,刘斌,李志英. 超声内镜指导下对肝硬化并发食管静脉曲张内镜下治疗的临床疗效及预后价值. 中国老年学杂志. 2021(08): 1634-1638 . 百度学术
8. 杨亚莉. 消化内镜下十二环连续套扎与六环单次套扎治疗食管静脉曲张的临床对比. 实用医技杂志. 2021(04): 521-523 . 百度学术
9. 高琰. 改良早期预警评分联合SBAR沟通模式在食管静脉曲张破裂出血患者中的应用效果. 中国民康医学. 2021(18): 159-161 . 百度学术
10. 黄学勤,张璋,许秋霞,曹火留,陈新带. 康复新液预防食管曲张静脉套扎术后再出血的疗效观察. 罕少疾病杂志. 2020(01): 27-28+42 . 百度学术
11. 张秋萌,刘辉,常紫薇,李兴雨,史旋,景丽伟,张超. 食管胃静脉曲张出血二级预防的内镜和介入治疗研究进展. 华北理工大学学报(医学版). 2020(03): 247-252 . 百度学术
12. 张迷春,马锦屏. 内镜下不同方法治疗食管静脉曲张破裂出血的效果及早期再出血的相关因素分析. 宁夏医科大学学报. 2020(09): 919-923 . 百度学术
13. 黄玉双,綦盛麟. 胃镜下套扎术治疗肝硬化食管静脉曲张破裂出血的疗效及安全性分析. 中国医疗器械信息. 2019(10): 38-39 . 百度学术
14. 鞠莹. 食管静脉曲张破裂出血内镜套扎术后病人延续护理中结构—过程—结果三维质量评价模式的应用效果. 全科护理. 2019(17): 2117-2120 . 百度学术
15. 温飞飞. 非选择性β受体阻滞剂联合内镜与TIPS治疗肝硬化食管静脉曲张比较. 肝脏. 2019(12): 1409-1412 . 百度学术
16. 崔美兰,贾彦生,闫会敏,康海燕,王艳,殷树英,郑欢伟. 内镜下密集套扎法治疗食管静脉曲张破裂出血的效果观察. 临床肝胆病杂志. 2018(08): 1683-1688 . 本站查看
17. 苏有盛,吴封. 康复新预防肝硬化食管静脉曲张套扎术后患者早期再出血效果分析. 内科. 2018(01): 67-69 . 百度学术
18. 麦国,王桢桢,柯达,邓颖,吴文娟. 食管静脉曲张套扎术联合内镜下硬化剂治疗对肝硬化上消化道出血的效果评价. 中国医学创新. 2018(16): 47-50 . 百度学术
19. 王庆娥,庄耘,徐馥,陈建平. 内镜下硬化与套扎术治疗食管静脉曲张破裂出血对照分析. 中国继续医学教育. 2017(32): 79-81 . 百度学术
20. 蔡建华. 分析肝硬化门脉高压症下食管静脉曲张破裂出血的危险因素. 世界最新医学信息文摘. 2017(A0): 102-103 . 百度学术
21. 王传芳,樊丽娟. 内镜治疗后口服卡维地洛预防肝硬化食管静脉曲张破裂出血患者再出血的效果分析. 中国中西医结合消化杂志. 2017(10): 755-758 . 百度学术
其他类型引用(10)
-